Access to necessary medications for illnesses such as HIV/AIDS can be a struggle for patients in emerging markets like Nigeria and other African countries. With pharmacists being the first point of access, patients are often required to visit them every month to receive their medications and to keep track of their drug use. This creates a tedious process for patients, which can result in low adherence and missed doses. However, a new technology-based solution is aiming to improve this situation by
A patient walks or is aided by someone else into the reception of a hospital. They walk to the counter and inform the attending nurse that they are seeking medical attention. The nurse asks, “do you have a file?” and the patient responds in the affirmative. The nurse goes to the inventory room, and 15 or more minutes are lost. The patient waits then the nurse returns with a file that looks like it is on the brink of falling apart
The partnership between LaFiya Telehealth and Tyto Care will advance telemedicine at home by accelerating the depth of clinical care that patients can get remotely in Nigeria. Today, LaFiya Telehealth and Tyto Care have partnered to accelerate the depth of clinical care given through telemedicine in Nigeria. The partnership brings an integration of their services to enable remote examinations with live streaming, information from Tyto Care Home kits and consequently allow for a more precise and detailed prognosis and early diagnosis.
Members of the pharmaceutical society of Nigeria at the 2021 Pharmaceutical Society of Nigeria in Port Harcourt commended RxAll a health tech company for the introduction of RxScanner into the country’s market at the unveiling of the product during the PSN conference held in Port Harcourt recently. Commenting on the unveiling of the product after the presentation, Pharmacist Olusola Porter, UCH Ibadan said “this technology will positively impact the counterfeit drug market in Africa, especially Nigeria while Pharmacist Uchechukwu Eloere of
European Medicines Agency’s (EMA) human medicines committee has recommended granting an extension of indication for the COVID-19 vaccine Comirnaty to include use in children aged 5 to 11. The vaccine, developed by BioNTech and Pfizer, is already approved for use in adults and children aged 12 and above. In children from 5 to 11 years of age, the dose of Comirnaty will be lower than that used in people aged 12 and above (10 µg compared with 30 µg).
Lafiya TeleHealth welcomes the arrival of innovative health care points kits to boost the APP and platform, this electronic health care point kits allows you to receive on-demand physical exams via live video chat with a doctor’s office using integrated medical exams devices transmits test results to an electronic health record for easy real time monitoring. The Kits goes beyond a phone or video chat with a doctor by providing an on-demand, clinic-quality medical exam right from your home or